Program
ASP-001
A development code. Also written as “ASP-001.1”.
Its studies are mostly in Erectile Dysfunction, led by Aspargo Labs.
Furthest: phase 1, since Jan 8, 20253 company-led studies, 3 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Aspargo Labs | 33 open or running | phase 1since Jan 8, 2025 | Jan 8, 2025 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 8, 2025First study: phase 1 study in Erectile DysfunctionFirst studyNCT06782659 · 56 planned · United States
- Mar 7, 2025Phase 1 study in Erectile DysfunctionNCT06872866 · 12 planned · United States
- Aug 5, 2025Phase 1 study in Erectile DysfunctionNCT07117383 · 72 planned · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07117383Erectile Dysfunction · United States | 1 | Not yet recruiting | Mar 2026 | 72 |
| NCT06872866Erectile Dysfunction · United States | 1 | Recruiting | Feb 28, 2026 | 12 |
| NCT06782659Erectile Dysfunction · United States | 1 | Not yet recruiting | Mar 2025 | 56 |
How it is read
Names in the registry
- “ASP-001”, 2 entries
- “ASP-001.1”, 1 entry
Codes read as this program: ASP001.
Conditions, from the studies’ own filings
- Erectile Dysfunction, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.